XOMA's extensive antibody expertise includes phage display
library construction, antibody discovery, optimization, preclinical and clinical development, regulatory affairs, and cGMP manufacturing.
The researchers' success demonstrates that antibody phage display
can be used to select antibodies for pathogen detection--even where traditional methods have proved inadequate.
Avidex can routinely produce high affinity mTCRs and is developing a new protein therapeutic platform based on phage display
Under the terms of the agreement with Cambridge Antibody, Micromet receives a worldwide licence in respect to all Cambridge Antibody's antibody phage display
technology patents, both pending and granted, to develop antibody-based products targeting the EpCAM antigen.
Chugai will use CAT's antibody phage display
libraries to enhance the efficiency of antibody-isolating processes for functional analysis and target validation of genes in its drug-discovery programs.
The key steps are the use of phage display
to identify the unique protein to act as the super-strong glue, and the subsequent cloning to make larger quantities.
For Dyax, it is the first time it has granted a license for the application of phage display
affinity technology for separations applications.
Dyax's phage display
technology has powered therapeutic and diagnostic candidate discovery across a wide range of therapeutic areas.
com)-- The program achievements were published in the Journal of Nucleic Acids titled “Practical Tips for Construction of Custom Peptide Libraries and Affinity Selection by Using Commercially Available Phage Display
today announce an agreement to expand access and freedom to operate under each other's phage display
Cambridge Antibody Technology (Cambridge, England) and Dyax Corporation (Cambridge, MA) announce an agreement to expand access and freedom to operate under each other's phage display
a privately held oncology company, announced today that Dyax has granted Eclipse an exclusive worldwide license for the development and commercialization of preclinical fully-human antibodies discovered using Dyax's gold-standard phage display
technology for use in oncology indications.